Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/119456
Campo DC Valoridioma
dc.contributor.authorRuiz-del-Arbol, Luisen_US
dc.contributor.authorMonescillo Francia, Alberto Fernandoen_US
dc.contributor.authorArocena, Carlosen_US
dc.contributor.authorValer, Pazen_US
dc.contributor.authorGinés, Pereen_US
dc.contributor.authorMoreira, Víctoren_US
dc.contributor.authorMilicua, José Maríaen_US
dc.contributor.authorJiménez, Wladimiroen_US
dc.contributor.authorArroyo, Vicenteen_US
dc.date.accessioned2022-11-28T18:28:19Z-
dc.date.available2022-11-28T18:28:19Z-
dc.date.issued2005en_US
dc.identifier.issn1527-3350en_US
dc.identifier.urihttp://hdl.handle.net/10553/119456-
dc.description.abstractThe pathogenic mechanism of hepatorenal syndrome is not well established. We investigated the circulatory function in cirrhosis before and after the development of hepatorenal syndrome. Systemic and hepatic hemodynamics and the activity of endogenous vasoactive systems were measured in 66 patients who had cirrhosis with tense ascites and normal serum creatinine levels; measurements were repeated at follow-up in 27 cases in whom hepatorenal syndrome had developed. At baseline, mean arterial pressure and cardiac output were significantly higher, and hepatic venous pressure gradient, plasma renin activity, and norepinephrine concentration were significantly lower in patients who did not develop hepatorenal syndrome compared with those presenting with this complication. Peripheral vascular resistance was decreased to the same extent in the two groups. Plasma renin activity and cardiac output were the only independent predictors of hepatorenal syndrome. Hepatorenal syndrome occurred in the setting of a significant reduction in mean arterial pressure (83 ± 9 to 75 ± 7 mmHg; P < .001), cardiac output (6.0 ± 1.2 to 5.4 ± 1.5 L/min; P < .01), and wegded pulmonary pressure (9.2 ± 2.6 to 7.5 ± 2.6 mmHg; P < .001) and an increase in plasma renin activity (9.9 ± 5.2 to 17.5 ± 11.4 ng/mL · hr; P < .001), norepinephrine concentration (571 ± 241 to 965 ± 502 pg/mL; P < .001), and hepatic venous pressure gradient. No changes were observed in peripheral vascular resistance. In conclusion, these data indicate that hepatorenal syndrome is the result of a decrease in cardiac output in the setting of a severe arterial vasodilation.en_US
dc.languageengen_US
dc.relation.ispartofHepatologyen_US
dc.sourceHepatology [1527-3350], v. 42(2), pp. 439-447 (Agosto 2005)en_US
dc.subject32 Ciencias médicasen_US
dc.subject3205 Medicina internaen_US
dc.subject.otherHepatorenal syndromeen_US
dc.subject.otherCirrhosisen_US
dc.subject.otherHepatic hemodynamicsen_US
dc.titleCirculatory function and hepatorenal syndrome in cirrhosisen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1002/hep.20766.en_US
dc.description.lastpage447en_US
dc.identifier.issue2-
dc.description.firstpage439en_US
dc.relation.volume42en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages9en_US
dc.utils.revisionen_US
dc.date.coverdateAgosto 2005en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr9,792
dc.description.jcrqQ1
dc.description.scieSCIE
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-9490-4427-
crisitem.author.fullNameMonescillo Francia, Alberto Fernando-
Colección:Artículos
Vista resumida

Visitas

63
actualizado el 13-jul-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.